Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

Journal of Clinical Investigation

Volumn 117, Issue 1, 2007, Pages 185-194

  Tacke, Frank ^a,e   Alvarez, David ^a   Kaplan, Theodore J ^a   Jakubzick, Claudia ^a   Spanbroek, Rainer ^b   Llodra, Jaime ^a   Garin, Alexandre ^a   Liu, Jianhua ^a   Mack, Matthias ^c   Van Rooijen, Nico ^d   Lira, Sergio A ^a   Habenicht, Andreas J ^b   Randolph, Gwendalyn J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CX3C CHEMOKINE; CX3C CHEMOKINE RECEPTOR 1; GLYCOPROTEIN P 15095; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD CELL COUNT; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL LABELING; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; LIPID DIET; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ATHEROSCLEROSIS; MICE; MODELS, ANIMAL; MONOCYTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE;

EID: 33845989083     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28549     Document Type: Article

References (49)

1. Gu, L., et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
2. Boring, L., Gosling, J., Cleary, M., and Charo, I.F. 1998. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
3. Huo, Y., et al. 2001. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J. Clin. Invest. 108:1307-1314. doi:10.1172/JCI200112877.
4. Kuziel, W.A., et al. 2003. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis. 167:25-32.
5. Zernecke, A., et al. 2006. Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10. Blood. 107:4240-4243.
6. Potteaux, S., et al. 2005. Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice. Mol. Med. 11:16-20.
7. Potteaux, S., et al. 2006. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26:1858-1863.
8. McDermott, D.H., et al. 2003. Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans. J. Clin. Invest. 111:1241-1250. doi:10.1172/JCI200316790.
9. Apostolakis, S., et al. 2006. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb. Res. 119:63-71. doi:10.1016/j.thromres.2005.12.016.
10. Lesnik, P., Haskell, C.A., and Charo, I.F. 2003. Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111:333-340. doi:10.1172/ JCI200315555.
11. Combadiere, C., et al. 2003. Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. Circulation. 107:1009-1016.
12. Teupser, D., et al. 2004. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc. Natl. Acad. Sci. U. S. A. 101:17795-17800.
13. Cybulsky, M.I., and Hegele, R.A. 2003. The fractalkine receptor CX3CR1 is a key mediator of atherogenesis. J. Clin. Invest. 111:1118-1120. doi:10.1172/JCI200318237.
14. Bursill, C.A., Channon, K.M., and Greaves, D.R. 2004. The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics. Curr. Opin. Lipidol. 15:145-149.
15. Palframan, R.T., et al. 2001. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194:1361-1373.
16. Geissmann, F., Jung, S., and Littman, D.R. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 19:71-82.
17. Ancuta, P., et al. 2003. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197:1701-1707.
18. Sunderkotter, C., et al. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-4417.
19. Qu, C., et al. 2004. Role of CCR8 and other chemokine pathways in the migration of monocytederived dendritic cells to lymph nodes. J. Exp. Med. 200:1231-1241.
20. Llodra, J., et al. 2004. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. U. S. A. 101:11779-117784.
21. Zhao, L., et al. 2004. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10:966-973.
22. Lindquist, R.L., et al. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5:1243-1250.
23. Randolph, G.J., Sanchez-Schmitz, G., Liebman, R.M., and Schakel, K. 2002. The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J. Exp. Med. 196:517-527.
24. Tacke, F., et al. 2006. Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J. Exp. Med. 203:583-594.
25. Germain, R.N., Miller, M.J., Dustin, M.L., and Nussenzweig, M.C. 2006. Dynamic imaging of the immune system: progress, pitfalls and promise. Nat. Rev. Immunol. 6:497-507.
26. Swirski, F.K., et al. 2006. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl. Acad. Sci. U. S. A. 103:10340-10345.
27. Jung, S., et al. 2000. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114.
28. Niess, J.H., et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 307:254-258. 29. Ginhoux, F., et al. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-273.
29. Yates, R.M., and Russell, D.G. 2005. Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. Immunity. 23:409-417.
30. Jung, S., et al. 2002. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:211-220.
31. Duffield, J.S., et al. 2005. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115:56-65. doi:10.1172/JCI200522675.
32. Van Rooijen, N., and Sanders, A. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods. 174:83-93.
33. Nibbering, P.H., Leijh, P.C., and van Furth, R. 1987. Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages. Immunology. 62:171-176.
34. Smalley, D.M., and Ley, K. 2005. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J. Cell. Mol. Med. 9:255-266.
35. Chereshnev, I., et al. 2003. Mouse model of heterotopic aortic arch transplantation. J. Surg. Res. 111:171-176.
36. Serbina, N.V., and Pamer, E.G. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7:311-317.
37. Weber, C., et al. 2000. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67:699-704.
38. Mack, M., et al. 2001. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166:4697-4704.
39. Cook, D.N., et al. 2001. Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell. Biol. 21:3159-3165.
40. Boring, L., et al. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-2561.
41. Kuziel, W.A., et al. 1997. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. U. S. A. 94:12053-12058.
42. Kurihara, T., Warr, G., Loy, J., and Bravo, R. 1997. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med. 186:1757-1762.
43. Charo, I.F., and Taubman, M.B. 2004. Chemokines in the pathogenesis of vascular disease. Circ. Res. 95:858-866.
44. Daly, C., and Rollins, B.J. 2003. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation. 10:247-257.
45. Lucas, A.D., et al. 2003. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation. 108:2498-2504.
46. Green, S.R., et al. 2006. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J. Immunol. 176:7412-7420.
47. Wong, B.W., Wong, D., and McManus, B.M. 2002. Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease. Cardiovasc. Pathol. 11:332-338.
48. Metlay, J.P., et al. 1990. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171:1753-1771.
49. Grisotto, M.G., et al. 2006. The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J. Clin. Invest. 116:1264-1273. doi:10.1172/JCI26666.